Cargando…
Ferroptosis is essential for diabetic cardiomyopathy and is prevented by sulforaphane via AMPK/NRF2 pathways
Herein, we define the role of ferroptosis in the pathogenesis of diabetic cardiomyopathy (DCM) by examining the expression of key regulators of ferroptosis in mice with DCM and a new ex vivo DCM model. Advanced glycation end-products (AGEs), an important pathogenic factor of DCM, were found to induc...
Autores principales: | Wang, Xiang, Chen, Xinxin, Zhou, Wenqian, Men, Hongbo, Bao, Terigen, Sun, Yike, Wang, Quanwei, Tan, Yi, Keller, Bradley B., Tong, Qian, Zheng, Yang, Cai, Lu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897044/ https://www.ncbi.nlm.nih.gov/pubmed/35256941 http://dx.doi.org/10.1016/j.apsb.2021.10.005 |
Ejemplares similares
-
Metallothionein Is Downstream of Nrf2 and Partially Mediates Sulforaphane Prevention of Diabetic Cardiomyopathy
por: Gu, Junlian, et al.
Publicado: (2017) -
Sulforaphane prevents angiotensin II‐induced cardiomyopathy by activation of Nrf2 through epigenetic modification
por: Su, Xuling, et al.
Publicado: (2021) -
Nrf2 expression and function, but not MT expression, is indispensable for sulforaphane-mediated protection against intermittent hypoxia-induced cardiomyopathy in mice
por: Zhou, Shanshan, et al.
Publicado: (2018) -
Sulforaphane Does Not Protect Right Ventricular Systolic and Diastolic Functions in Nrf2 Knockout Pulmonary Artery Hypertension Mice
por: Zhang, Guangyan, et al.
Publicado: (2022) -
Sulforaphane prevents angiotensin II-induced cardiomyopathy by activation of Nrf2 via stimulating the Akt/GSK-3ß/Fyn pathway
por: Xin, Ying, et al.
Publicado: (2018)